{"id":"W4410884998","doi":"10.1016/j.annonc.2025.05.011","title":"Enzalutamide plus radium-223 in metastatic castration-resistant prostate cancer: results of the EORTC 1333/PEACE-3 trial","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Astellas Pharma Europe; Astellas Pharma; Bayer HealthCare; Bayer; Astellas Pharma US","keywords":"Medicine; Enzalutamide; Prostate cancer; Radium-223; Oncology; Internal medicine; Cancer; Radium; Urology; Radiochemistry; Bone metastasis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008541383,0.0001349873,0.0006156209,0.0002211606,0.00004932317,0.000005513069,0.0001627483,0.00009057681,0.00003060343],"category_scores_gemma":[0.0004332197,0.00008598126,0.0001426063,0.0005964008,0.0003117172,0.00005000383,0.0000660158,0.0002372474,0.000001794119],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002354191,"about_ca_system_score_gemma":0.003344409,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002603347,"about_ca_topic_score_gemma":0.002918507,"domain_scores_codex":[0.9981109,0.0002814253,0.0007450313,0.0002496586,0.0002859927,0.0003270224],"domain_scores_gemma":[0.9986668,0.0003706139,0.0002902042,0.0003247213,0.0002825631,0.00006511518],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7381074,0.004348917,0.006932773,0.001492669,0.001874738,0.0005029892,0.00710113,0.0007216092,0.05920088,0.00345097,0.04779778,0.1284682],"study_design_scores_gemma":[0.4727734,0.01704475,0.07321792,0.001730435,0.0007021416,0.00002085608,0.002562183,0.0003641329,0.299612,0.004322683,0.1272686,0.0003809452],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.959024,0.004674592,0.000002173006,0.02504957,0.0003867949,0.001985349,0.0001899581,0.00001028216,0.008677294],"genre_scores_gemma":[0.9905156,0.00302608,0.0000847287,0.0004073342,0.00005081213,0.0001863692,0.00002965722,0.000009690458,0.005689722],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.265334,"threshold_uncertainty_score":0.5932838,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1190364184841984,"score_gpt":0.4541410662425793,"score_spread":0.3351046477583809,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}